Total Payments
$6,181
2024 Payments
$1,129
Companies
40
Transactions
334
Medicare Patients
8,888
Medicare Billing
$658,996
Payment Breakdown by Category
Food & Beverage$6,019 (97.4%)
Education$162.54 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,019 | 331 | 97.4% |
| Education | $162.54 | 3 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,167 | 72 | $0 (2024) |
| ABBVIE INC. | $935.03 | 55 | $0 (2024) |
| Lilly USA, LLC | $679.35 | 34 | $0 (2024) |
| Astellas Pharma US Inc | $545.03 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $263.78 | 13 | $0 (2024) |
| Amarin Pharma Inc. | $230.94 | 13 | $0 (2022) |
| Abbott Laboratories | $215.48 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $194.59 | 10 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $187.43 | 12 | $0 (2024) |
| PFIZER INC. | $182.94 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,129 | 57 | ABBVIE INC. ($290.24) |
| 2023 | $1,319 | 65 | Astellas Pharma US Inc ($367.35) |
| 2022 | $1,257 | 71 | ABBVIE INC. ($313.93) |
| 2021 | $655.42 | 42 | AbbVie Inc. ($252.61) |
| 2020 | $732.17 | 42 | Novo Nordisk Inc ($179.39) |
| 2019 | $216.57 | 13 | Novo Nordisk Inc ($38.19) |
| 2018 | $211.27 | 14 | PFIZER INC. ($40.27) |
| 2017 | $661.60 | 30 | Novo Nordisk Inc ($219.21) |
All Payment Transactions
334 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $34.40 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Gastroenterology | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: VACCINE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Biological | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Biological | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: Biological | ||||||
| 08/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Biological | ||||||
| 07/11/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.74 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,365 | 2,978 | $551,149 | $159,779 |
| 2022 | 25 | 2,646 | 3,425 | $683,853 | $229,432 |
| 2021 | 24 | 1,750 | 2,186 | $399,116 | $132,141 |
| 2020 | 31 | 2,127 | 2,877 | $449,011 | $137,644 |
Total Patients
8,888
Total Services
11,466
Medicare Billing
$658,996
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 381 | 381 | $136,398 | $51,486 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 363 | 535 | $162,741 | $34,364 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 304 | 483 | $99,498 | $20,342 | 20.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 124 | 124 | $20,212 | $8,916 | 44.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 338 | 338 | $17,238 | $6,588 | 38.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 42 | $17,123 | $4,529 | 26.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 20 | $13,100 | $4,437 | 33.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 130 | 130 | $9,490 | $4,225 | 44.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 265 | 430 | $4,240 | $3,587 | 84.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 11 | 92 | $13,524 | $3,509 | 25.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 20 | 20 | $9,240 | $3,470 | 37.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $7,944 | $3,380 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $9,320 | $2,280 | 24.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 13 | $6,032 | $2,112 | 35.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 16 | 16 | $3,568 | $2,093 | 58.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $7,956 | $1,631 | 20.5% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 159 | 159 | $7,632 | $1,197 | 15.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 28 | 28 | $2,044 | $910.00 | 44.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 48 | $3,216 | $514.50 | 16.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 41 | 49 | $441.00 | $167.09 | 37.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 12 | 12 | $192.00 | $41.00 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 333 | 582 | $176,928 | $53,441 | 30.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 379 | 379 | $135,201 | $52,793 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 298 | 456 | $93,936 | $30,382 | 32.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 228 | 228 | $54,492 | $19,502 | 35.8% |
About Dr. Debra Curtis, M.D
Dr. Debra Curtis, M.D is a Internal Medicine healthcare provider based in Catonsville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083729065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debra Curtis, M.D has received a total of $6,181 in payments from pharmaceutical and medical device companies, with $1,129 received in 2024. These payments were reported across 334 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,019).
As a Medicare-enrolled provider, Curtis has provided services to 8,888 Medicare beneficiaries, totaling 11,466 services with total Medicare billing of $658,996. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Catonsville, MD
- Active Since 08/20/2006
- Last Updated 01/22/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083729065
Products in Payments
- VRAYLAR (Drug) $438.27
- Ozempic (Drug) $426.38
- Rybelsus (Drug) $393.11
- Veozah (Drug) $375.82
- JARDIANCE (Drug) $307.62
- UBRELVY (Drug) $252.17
- TRULICITY (Drug) $241.73
- Vascepa (Drug) $230.94
- MOUNJARO (Drug) $202.14
- NURTEC ODT (Drug) $200.32
- QULIPTA (Drug) $186.50
- Cologuard Collection Kit (Device) $170.93
- XIFAXAN (Drug) $149.41
- FARXIGA (Drug) $133.63
- QUVIVIQ (Drug) $123.74
- NIOX VERO DEVICE (Device) $110.00
- Tresiba (Drug) $110.00
- Victoza (Drug) $106.03
- EMGALITY (Drug) $101.75
- ZOSTAVAX (Biological) $88.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Catonsville
Charles Moore, M.d, M.D
Internal Medicine — Payments: $10,315
Internal Medicine $10,315
Dr. Robert Ammlung, M.d, M.D
Internal Medicine — Payments: $8,640
Internal Medicine $8,640
Dr. Scott Poulton, M.d, M.D
Internal Medicine — Payments: $8,200
Internal Medicine $8,200
Dr. Benjamin Lee, M.d, M.D
Internal Medicine — Payments: $6,688
Internal Medicine $6,688
Douglas Pinto, Md, MD
Internal Medicine — Payments: $5,781
Internal Medicine $5,781
Dr. Gregory Levickas, Md, MD
Internal Medicine — Payments: $4,697
Internal Medicine $4,697